Robert W. Baird Cuts Healthpeak Properties (NYSE:DOC) Price Target to $22.00

Healthpeak Properties (NYSE:DOC - Get Free Report) had its price objective reduced by equities research analysts at Robert W. Baird from $24.00 to $22.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm presently has an "outperform" rating on the real estate investment trust's stock. Robert W. Baird's price target would indicate a potential upside of 23.80% from the company's current price.

A number of other research firms also recently issued reports on DOC. StockNews.com downgraded shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a research report on Wednesday, April 23rd. Scotiabank reduced their price objective on Healthpeak Properties from $24.00 to $23.00 and set a "sector outperform" rating for the company in a report on Friday, February 28th. Evercore ISI lowered their target price on Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating on the stock in a report on Monday. Morgan Stanley upgraded Healthpeak Properties from an "equal weight" rating to an "overweight" rating and set a $25.00 price target for the company in a research report on Wednesday, January 15th. Finally, Wedbush decreased their price objective on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a research report on Monday. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $23.27.

Healthpeak Properties Trading Down 0.3 %

NYSE:DOC opened at $17.77 on Tuesday. Healthpeak Properties has a 1 year low of $17.33 and a 1 year high of $23.26. The company has a debt-to-equity ratio of 0.96, a quick ratio of 1.35 and a current ratio of 1.35. The stock has a fifty day moving average price of $19.53 and a two-hundred day moving average price of $20.53. The stock has a market capitalization of $12.43 billion, a price-to-earnings ratio of 50.77, a PEG ratio of 2.17 and a beta of 1.02.

Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its quarterly earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.46. The business had revenue of $702.89 million during the quarter, compared to the consensus estimate of $690.76 million. Healthpeak Properties had a net margin of 9.00% and a return on equity of 2.61%. The business's revenue was up 15.9% compared to the same quarter last year. During the same quarter last year, the firm posted $0.45 EPS. As a group, sell-side analysts anticipate that Healthpeak Properties will post 1.86 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Healthpeak Properties news, Director John T. Thomas bought 4,200 shares of Healthpeak Properties stock in a transaction that occurred on Monday, April 28th. The shares were purchased at an average cost of $17.84 per share, for a total transaction of $74,928.00. Following the completion of the transaction, the director now owns 813,566 shares of the company's stock, valued at $14,514,017.44. This represents a 0.52 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Scott M. Brinker purchased 11,337 shares of the stock in a transaction on Monday, April 28th. The stock was acquired at an average price of $17.68 per share, with a total value of $200,438.16. Following the acquisition, the chief executive officer now directly owns 201,863 shares in the company, valued at $3,568,937.84. This trade represents a 5.95 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 0.23% of the company's stock.

Hedge Funds Weigh In On Healthpeak Properties

A number of hedge funds have recently made changes to their positions in the stock. JPMorgan Chase & Co. increased its holdings in shares of Healthpeak Properties by 23.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust's stock worth $493,115,000 after buying an additional 4,056,931 shares during the last quarter. Diamant Asset Management Inc. purchased a new stake in Healthpeak Properties during the third quarter valued at about $564,000. Vert Asset Management LLC increased its stake in Healthpeak Properties by 11.1% during the fourth quarter. Vert Asset Management LLC now owns 304,219 shares of the real estate investment trust's stock worth $6,167,000 after acquiring an additional 30,461 shares during the last quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund increased its stake in Healthpeak Properties by 25.7% during the fourth quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 109,200 shares of the real estate investment trust's stock worth $2,213,000 after acquiring an additional 22,300 shares during the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. raised its holdings in shares of Healthpeak Properties by 16.6% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 110,498 shares of the real estate investment trust's stock worth $2,217,000 after purchasing an additional 15,753 shares during the period. Institutional investors and hedge funds own 93.57% of the company's stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.